U.S. Markets closed

Aethlon Medical, Inc. (AEMD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7700-0.0300 (-1.67%)
At close: 4:00PM EST

Aethlon Medical, Inc.

9635 Granite Ridge Drive
Suite 100
San Diego, CA 92123
United States
858 459 7800
http://www.aethlonmedical.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees8

Key Executives

NameTitlePayExercisedYear Born
Dr. Charles J. Fisher Jr.CEO, Director & Member of Extracorporeal Therapy Advisory Board124kN/A1947
Mr. James B. FrakesCFO, Sr. VP of Fin. & Sec.354.75kN/A1957
Mr. Sunil SawhneyHead of Clinical StudiesN/AN/AN/A
Dr. Richard H. TullisConsultantN/AN/A1945
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. The company is based in San Diego, California.

Corporate Governance

Aethlon Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.